|
| LATS1/2 kinases trigger selfrenewal of cancer stem cells in aggressive oral cancer |
|
https://doi.org/10.18632/oncotarget.26583
Masami Nozaki, Norikazu Yabuta, Moe Fukuzawa, Satomi Mukai, Ayumi Okamoto, Towa Sasakura, Kohshiro Fukushima, Yoko Naito, Gregory D. Longmore, and Hiroshi Nojima
|
| 1014-1030 |
|
| Therapeutic potential of nimotuzumab PEGylatedmaytansine antibody drug conjugates against EGFR positive xenograft |
|
https://doi.org/10.18632/oncotarget.26613
Siddesh V. Hartimath, Ayman El-Sayed, Amal Makhlouf, Wendy Bernhard, Carolina Gonzalez, Wayne Hill, Angel Casaco Parada, Kris Barreto, Clarence Ronald Geyer, and Humphrey Fonge
|
| 1031-1044 |
|
| Glypican1 and glycoprotein 2 bearing extracellular vesicles do not discern pancreatic cancer from benign pancreatic diseases |
|
https://doi.org/10.18632/oncotarget.26620
Fabrice Lucien, Vivian Lac, Daniel D. Billadeau, Ayelet Borgida, Steven Gallinger, and Hon S. Leong
|
| 1045-1055 |
|
| Src kinase inhibition restores Ecadherin expression in dasatinibsensitive pancreatic cancer cells |
|
https://doi.org/10.18632/oncotarget.26621
Austin R. Dosch, Xizi Dai, Alexander A. Gaidarski III, Chanjuan Shi, Jason A. Castellanos, Michael N. VanSaun, Nipun B. Merchant, and Nagaraj S. Nagathihalli
|
| 1056-1069 |
|
| Safety and effectiveness of FOLFOXIRI plus molecular target drug therapy for metastatic colorectal cancer: A multicenter retrospective study |
|
https://doi.org/10.18632/oncotarget.26626
Takatsugu Ogata, Hironaga Satake, Misato Ogata, Yukimasa Hatachi, Hayato Maruoka, Daisuke Yamashita, Hiroki Hashida, Madoka Hamada, and Hisateru Yasui
|
| 1070-1084 |
|
| Andrographolide induces DNA damage in prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.26628
Ingrid S. Forestier-Román, Andrés López-Rivas, MarÃa M. Sánchez-Vázquez, Krizia Rohena-Rivera, Gretchen Nieves-Burgos, Humberto Ortiz-Zuazaga, Carlos A. Torres-Ramos, and Magaly MartÃnez-Ferrer
|
| 1085-1101 |
|
| Oxalate induces type II epithelial to mesenchymal transition EMT in inner medullary collecting duct cells IMCD in vitro and stimulate the expression of osteogenic and fibrotic markers in kidney medulla in vivo |
|
https://doi.org/10.18632/oncotarget.26634
Marcia Convento, Edson Pessoa, Alef Aragão, Nestor Schor, and Fernanda Borges
|
| 1102-1118 |
|
| The correlation of p22phox and chemosensitivity in EGFRTKI resistant lung adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.26637
Masayuki Kobayashi, Ryoko Saito, Yasuhiro Miki, Ren Nanamiya, Chihiro Inoue, Jiro Abe, Ikuro Sato, Yoshinori Okada, and Hironobu Sasano
|
| 1119-1131 |
|
| Repurposing old carbon monoxidereleasing molecules towards the antiangiogenic therapy of triplenegative breast cancer |
|
https://doi.org/10.18632/oncotarget.26638
Malamati Kourti, Andrew Westwell, Wen Jiang, and Jun Cai
|
| 1132-1148 |
|
| Reliable evaluation of tumorinfiltrating lymphocytes in pancreatic cancer tissue biopsies |
|
https://doi.org/10.18632/oncotarget.26646
Yoshinori Ino, Seiji Oguro, Rie Yamazaki-Itoh, Shutaro Hori, Kazuaki Shimada, and Nobuyoshi Hiraoka
|
| 1149-1159 |
|
| Nterminal probrain natriuretic peptide reflects both left ventricular diastolic dysfunction and myelomarelated renal insufficiency and robustly predicts mortality in patients with symptomatic multiple myeloma |
|
https://doi.org/10.18632/oncotarget.26647
Yoshiaki Abe, Tetsuya Kobayashi, Yoshiaki Usui, Kentaro Narita, Hiroki Kobayashi, Akihiro Kitadate, Daisuke Miura, Masami Takeuchi, and Kosei Matsue
|
| 1160-1170 |
